Baseline D-dimer as a predictor of immune checkpoint inhibitor efficacy in cancer
{{output}}
Background: Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by enhancing antitumor immunity, yet durable responses are observed in only a fraction of patients. Identifying accessible and reliable biomarke... ...
